Davis's Drug Guide
Ortho Tri-Cyclen-28
Phase I
norgestimate 0.18 mg + ethinyl estradiol 35 mcg
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Ortho Tri-Cyclen-28." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110266/0/Ortho_Tri_Cyclen_28.
Vallerand AHA, Sanoski CAC, Quiring CC. Ortho Tri-Cyclen-28. Davis's Drug Guide. F.A. Davis Company; 2024. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110266/0/Ortho_Tri_Cyclen_28. Accessed November 3, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Ortho Tri-Cyclen-28. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110266/0/Ortho_Tri_Cyclen_28
Vallerand AHA, Sanoski CAC, Quiring CC. Ortho Tri-Cyclen-28 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 November 03]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110266/0/Ortho_Tri_Cyclen_28.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ortho Tri-Cyclen-28
ID - 110266
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110266/0/Ortho_Tri_Cyclen_28
PB - F.A. Davis Company
ET - 19
DB - Pediatrics Central
DP - Unbound Medicine
ER -
